IL6 and diabetic kidney disease: Figure 7 shows the significantly higher plasma levels of TNF-α, IFN-γ, TGF-β, and IL-6 in patients with diabetic nephropathy (stage 3a and 3b) and microalbuminuria (Table 1) compared to the levels seen in DMT2N0 patients (Figure 7A–D).